ELSEVIER Philadelphia, August 10, 2022 – Psoriasis is a chronic inflammatory, debilitating skin disorder. Although there is no cure for psoriasis, several treatment options can inhibit inflammation and relieve signs and symptoms of this disease. In this novel study in the Journal of Investigative Dermatology, published by Elsevier, investigators report surprising results for treating psoriasis using epidural lidocaine injections. “Case...
Month: <span>August 2022</span>
Post
3 Myths You Didn’t Know About Your Brain
BY KEN KAWADA AUG 9, 2022 BEN REIN In part 1 of our neuroscience expert series with social media science communicator Ben Rein, I sat down with him to discuss all things brain. Rein, a neuroscientist at Stanford University, amassed a large following after one of his videos went viral in 2020. Since then, he has dedicated...
Post
MIT develops rapid at-home test to measure COVID immunity
By Rich Haridy August 09, 2022 A test developed at MIT requires a single drop of blood and delivers results in around 20 minutes Courtesy of the researchers/edited by MIT News An innovative new test developed by researchers at MIT promises to offer people the ability to quickly and easily measure their COVID-19 immunity. The...
Post
Origins of germ cell tumors suggest possible opportunities for future treatment
by Wellcome Trust Sanger Institute The relationship between GCT genome and transcriptome. a Heatmap showing gene enrichment per GCT tissue relative to healthy seminiferous tubules, binned by cytoband. Colors correspond to significance of enrichment according to the adjusted p-value (false discovery rate correction). The number next to each histology is the number of eligible microbiopsies...
Post
Social media posts warn people not to call 988. Here’s what you need to know
August 11, 2022 5:00 AM ET ANERI PATTANI When the 988 Suicide & Crisis Lifeline launched last month, many mental health providers, researchers and advocates celebrated. Although a national suicide hotline had existed for years, finally there was an easy-to-remember three-digit number for people to call, they said. The shorter number would serve as an...
Post
Potential long-term treatment for asthma found
by Aston University Credit: Pixabay/CC0 Public Domain A possible way to tackle one of the underlying causes of asthma has been developed by researchers from Aston University and Imperial College London. In tests in mice, the researchers were able to virtually eliminate asthmatic symptoms within two weeks and return their airways to near normal. Just under...
Post
Study describes new ‘molecular tool’ to trigger targeted immune responses
by University of Oklahoma Credit: CC0 Public Domain A research team at the University of Oklahoma published a study in the journal Advanced Science that presents a new approach to triggering an adaptive immune response. The study was led by Handan Acar, Ph.D., the Peggy and Charles Stephenson Assistant Professor of Biomedical Engineering in the Gallogly College of...
Post
9 Medications You Should Take on an Empty Stomach
Written by Kristianne Hannemann, PharmD | Reviewed by Austin Ulrich, PharmD, BCACP Published on July 14, 2022 Key takeaways: Some medications work better when taken on an empty stomach. Common examples include thyroid medications, bisphosphonates, and sucralfate (Carafate). The general rule of thumb is to take your medication either 1 hour before or 2 hours...
Post
Research applies microrobotics in endodontic treatment, diagnostics
by University of Pennsylvania Magnetically actuated 3D molded robots are controlled precisely to target the apical region of the root canal uninterrupted by the surrounding periodontium as visualized and tracked by CBCT. Credit: Penn Dental Medicine With its irregularities and anatomical complexities, the root canal system is one of the most clinically challenging spaces in the...
Post
DyAnsys Neurostimulation Device Approved for Neuropathic Pain
BY QUINN PHILLIPS | JANUARY 1, 1970 The U.S. Food and Drug Administration (FDA) has approved a neurostimulation device from DyAnsys, Inc., to treat pain related to diabetic peripheral neuropathy, according to a press release from the company. The newly approved device, called First Relief, is what’s known as a PENS (percutaneous electrical neurostimulation) device. That means...